SCHEMBL1503540

SCHEMBL1503540

C[C@](CNC(=O)c1ccc(O)cc1)(C(=O)O)N1CCOCC1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
PKM P14618 1/20 0.52
NAMPT P43490 5/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 1/20 0.47
CNR2 P34972 2/20 0.45
CNR1 P21554 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
MEN1 O00255 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1503635 0.87 NPC1 (0.49) ALDH1A1PKMCNR2CNR1MAPT
SCHEMBL1504684 0.82 ALDH1A1 (0.42) ALDH1A1PKMKDM4ECNR2CNR1
SCHEMBL1503561 0.81 ADAM17 (0.58) ALDH1A1PKML3MBTL1MAPTHPGD
SCHEMBL1503650 0.81 ALDH1A1 (0.59) ALDH1A1PKMNAMPTL3MBTL1KDM4E
SCHEMBL2680367 0.78 KMT2A (0.52) ALDH1A1PKML3MBTL1MEN1TSHR
SCHEMBL16565833 0.76 ALDH1A1 (0.67) ALDH1A1PKMNAMPTL3MBTL1KDM4E
SCHEMBL17886704 0.75 ALDH1A1 (0.69) ALDH1A1PKMNAMPTL3MBTL1KDM4E
SCHEMBL17888350 0.75 ALDH1A1 (0.69) ALDH1A1PKMNAMPTL3MBTL1KDM4E
SCHEMBL9291268 0.72 ALDH1A1 (0.70) ALDH1A1PKML3MBTL1KDM4EMAPT
SCHEMBL1503621 0.72 USP2 (0.46) ALDH1A1L3MBTL1KDM4EMAPTCD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011033010-A1 4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-03-24 WO disclosed